With no exemptions for medical devices from Trump’s double-digit tariffs, pacemakers, insulin pumps and hearing aids could ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

This week, federal health officials finalized a set of rules tied to the last leg of the 2022 Inflation Reduction Act. The ...

The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...

Construction will begin this year. While Civica has been working to introduce affordable insulin, its competitors have lowered their prices. In 2023, the three largest insulin producers in the U.S ...

The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and ...

A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings ...

The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...